Sudden Death in Familial Polymorphic Ventricular Tachycardia Associated With Calcium Release Channel (Ryanodine Receptor) Leak
- 29 June 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (25) , 3208-3214
- https://doi.org/10.1161/01.cir.0000132472.98675.ec
Abstract
Background— Familial polymorphic ventricular tachycardia (FPVT) is characterized by exercise-induced arrhythmias and sudden cardiac death due to missense mutations in the cardiac ryanodine receptor (RyR2), an intracellular Ca 2+ release channel required for excitation-contraction coupling in the heart. Methods and Results— Three RyR2 missense mutations, P2328S, Q4201R, and V4653F, which occur in Finnish families, result in similar mortality rates of ≈33% by age 35 years and a threshold heart rate of 130 bpm, above which exercise induces ventricular arrhythmias. Exercise activates the sympathetic nervous system, increasing cardiac performance as part of the fight-or-flight stress response. We simulated the effects of exercise on mutant RyR2 channels using protein kinase A (PKA) phosphorylation. All 3 RyR2 mutations exhibited decreased binding of calstabin2 (FKBP12.6), a subunit that stabilizes the closed state of the channel. After PKA phosphorylation, FPVT-mutant RyR2 channels showed a significant gain-of-function defect consistent with leaky Ca 2+ release channels and a significant rightward shift in the half-maximal inhibitory Mg 2+ concentration (IC 50 ). Treatment with the experimental drug JTV519 enhanced binding of calstabin2 to RyR2 and normalized channel function. Conclusions— Sympathetic activation during exercise induces ventricular arrhythmias above a threshold heart rate in RyR2 mutation carriers. Simulating the downstream effects of the sympathetic activation by PKA phosphorylation of RyR2 channels containing these FPVT missense mutations produced a consistent gain-of-function defect. RyR2 function and calstabin2 depletion were rescued by JTV519, suggesting stabilization of the RyR2 channel complex may represent a molecular target for the treatment and prevention of exercise-induced arrhythmias and sudden death in these patients. (Circulation. 2004;109:3208-3214.)Keywords
This publication has 23 references indexed in Scilit:
- Protection from Cardiac Arrhythmia Through Ryanodine Receptor-Stabilizing Protein Calstabin2Science, 2004
- Ca 2+ /Calmodulin-Dependent Protein Kinase II Phosphorylation Regulates the Cardiac Ryanodine ReceptorCirculation Research, 2004
- Abnormal Ca 2+ Release, but Normal Ryanodine Receptors, in Canine and Human Heart FailureCirculation Research, 2002
- Cardiac excitation–contraction couplingNature, 2002
- Phosphorylation-Dependent Regulation of Ryanodine ReceptorsThe Journal of cell biology, 2001
- FKBP12 Binding Modulates Ryanodine Receptor Channel GatingJournal of Biological Chemistry, 2001
- PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor): Defective Regulation in Failing HeartsPublished by Elsevier ,2000
- The Ryanodine Receptor from Canine Heart Sarcoplasmic Reticulum Is Associated with a Novel FK-506 Binding ProteinBiochemical and Biophysical Research Communications, 1994
- Low extracellular magnesium induces intracellular free Mg deficits, ischemia, depletion of high-energy phosphates and cardiac failure in intact working rat hearts: A 31P-NMR studyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1993
- Depressant effect of magnesium on early afterdepolarizations and triggered activity induced by cesium, quinidine, and 4-aminopyridine in canine cardiac Purkinje fibersAmerican Heart Journal, 1989